TRADING UPDATES: Avacta appoints "seasoned" new deputy chair
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News: Read More
| Price | 65.00p on 10-08-2026 at 17:45:05 |
|---|---|
| Change | -2.00p -2.99% |
| Buy | 66.00p |
| Sell | 64.00p |
| Last Trade: | Sell 6,000.00 at 64.377p |
| Day's Volume: | 1,158,850 |
| Last Close: | 65.00p |
| Open: | 67.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 65.00p - 67.00p |
| 52wk Range: | 42.70p - 90.50p |
| Market Capitalisation: | £304.56m |
| VWAP: | 66.039p |
| Shares in Issue: | 468.55m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 6,000 | 64.377p | Ordinary |
16:29:08 - 10-Aug-26 |
| Buy* | 20,219 | 65.25p | Ordinary |
16:28:30 - 10-Aug-26 |
| Sell* | 2,000 | 64.375p | Ordinary |
16:28:22 - 10-Aug-26 |
| Sell* | 4,171 | 64.375p | Ordinary |
16:28:06 - 10-Aug-26 |
| Unknown* | 25,000 | 65.00p | Ordinary |
16:27:12 - 10-Aug-26 |
| Sell* | 4,521 | 64.35p | Ordinary |
16:26:50 - 10-Aug-26 |
| Sell* | 25,000 | 65.00p | Ordinary |
16:26:49 - 10-Aug-26 |
| Sell* | 5,000 | 65.111p | Ordinary |
16:26:38 - 10-Aug-26 |
| Sell* | 10,000 | 65.1143p | Ordinary |
16:26:35 - 10-Aug-26 |
| Sell* | 10,000 | 65.1143p | Ordinary |
16:25:35 - 10-Aug-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Jul 2026 7:00 am | RNS | Accelerated Amortized Payment of Bond Installment |
| 8th Jul 2026 7:00 am | RNS | Avacta Appoints Patrick Vink Deputy Chairman |
| 25th Jun 2026 7:00 am | RNS | Platform-Validating Data with Faridoxorubicin |
| 25th Jun 2026 7:00 am | RNS | FDA Agreement on Pivotal Trial Design for AVA6000 |
| 23rd Jun 2026 7:00 am | RNS | Result of AGM |
| 22nd Jun 2026 7:00 am | RNS | Year-to-date business update ahead of AGM |
| 5th Jun 2026 7:00 am | RNS | Oversubscribed Strategic Equity Fundraise of £9m |
| 1st Jun 2026 3:00 pm | RNS | Block Listing - Application to AIM |
| 1st Jun 2026 7:00 am | RNS | Clinical data on AVA6000 in salivary gland cancers |
| 29th May 2026 7:00 am | RNS | Posting of Annual Report and Notice of AGM |